News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at


10 August 2022

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in July

Check out what MTPConnect got up to in July!

09 August 2022

TTRA Staff Changes

Staff movements mean some interim changes are being made in the Targeted Translation Research Accelerator (TTRA) team.

27 July 2022

MTPConnect’s CTCM program launches next funding opportunity to boost commercialisation of Australian medical devices

The Clinical Translation and Commercialisation Medtech (CTCM) Program, a Medical Research Future Fund (MRFF) initiative delivered by MTPConnect, will open its second round in September 2022. Applications are sought from Australian small to medium-sized enterprises (SMEs) developing home-grown medical devices.

26 July 2022

The WILD Program Opens for Applications

Are you a STEM Leader? The Women in Leadership Development (WILD) Program for 2023 is now open for applications!

25 July 2022

TIA partners with AAMRNet to accelerate therapeutic development research

TIA is using its Pipeline Accelerator scheme to support three research projects targeting antimicrobial resistance (AMR), with additional funding provided by the MTPConnect-operated Australian Antimicrobial Resistance Network (AAMRNet).

22 July 2022

Australian Clinical Entrepreneur Program Applications Now Open!

Applications are now open for the Australian Clinical Entrepreneur Program (AUSCEP), made possible by our REDI initiative. The Program has been co-designed by clinicians for clinicians and aims to develop entrepreneurial skills and networks to build better healthcare.

15 July 2022

Report for TGA on 'Cell, Gene and Tissue Regulatory Framework in Australia: Stakeholder Perspectives' Published

The Therapeutic Goods Administration (TGA) commissioned MTPConnect to conduct a stakeholder review of the regulatory framework for gene, cell and tissue therapies in Australia and the report has recently been published.

15 July 2022

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in June

Check out what MTPConnect got up to in June!

14 July 2022

Industry Fellowships Awarded to Push Australian Pharma and MedTech Research Towards Commercialisation

Twenty pharmaceutical and MedTech researchers, entrepreneurs and innovators from around Australia have been awarded industry-based fellowships to boost skills and advance their research or technology towards commercialisation.

11 July 2022

Tori Mynard appointed as Associate Project Manager for the REDI initiative

Today we are delighted to announce that Victoria (Tori) Mynard is re-joining MTPConnect to take up a 3-month role of Associate Project Manager for our Researcher Exchange and Development Within Industry (REDI) initiative, based in Melbourne.

30 June 2022

Introducing Jo Glew - Project Officer, Diagnostics Industry Engagement

We are delighted to announce the appointment of Jo Glew as the Project Officer, Diagnostics Industry Engagement team, based in Perth.

29 June 2022

Health Horizon LIVE Feeds now tracking BMTH and WA Innovations

If you want to keep on top of medtech, pharmaceutical and digital health (MTP) innovation projects, Health Horizon Projects Tracker live feeds allow you to do just this. This new tracking feature is now on our website for you to follow the progress of BioMedTech Horizons-funded (BMTH) projects and all Western Australia-based MTP projects.

15 June 2022

Call out for entries to the Australian Technologies Competition

The Australian Technologies Competition is an internationally recognised national awards and international growth support program for technology scaleups. Entries for the Healthtech award category close 4 July 2022!

14 June 2022

REDI Investor Workshops – Demystifying Investing in Healthtech

MTPConnect’s Researcher Exchange and Development Within Industry (REDI) Initiative is running a series of three Investor Workshops to demystify investing in the healthtech sector.